The Restoring Safeguards for Dangerous Abortion Drugs Act would effectively prohibit the mailing of Mifepristone, an abortion drug.

Conservatives have criticized the abortion medication, particularly after it became available through telehealth.

United States Secretary of Health and Human Services, Robert F. Kennedy Jr., has launched an investigation into a popular ...

A letter from HHS Secretary Robert F Kennedy Jr. and FDA Commissioner Martin Makary, in which they confirmed that the FDA is ...

The Trump administration is facing conflicting political pressures after Health Secretary Robert F. Kennedy Jr. said the Food ...

The Food and Drug Administration will review evidence about the safety and efficacy of the abortion drug Mifepristone.

Currently, telehealth accounts for a quarter of abortions in the U.S., and in 2023, nearly two-thirds of abortions were done ...

The Trump administration said it will review the medication abortion drug mifepristone (Mifeprex) to see whether current ...

The US Food and Drug Administration is reviewing evidence about the safety and efficacy of mifepristone, one of the drugs ...

Data analyzed by CNN shows mifepristone — the first drug in the medication abortion process — is even safer than some common, low-risk prescription drugs, including penicillin and Viagra.

HHS and FDA launch review of abortion pill mifepristone after disputed safety study, sparking backlash from abortion rights advocates.

Mifepristone is the primary way abortions continue in states with bans, because it can be prescribed and sent via telehealth.